Stay updated on INEC: Irradiation and Nivolumab in Esophageal Cancer Clinical Trial
Sign up to get notified when there's something new on the INEC: Irradiation and Nivolumab in Esophageal Cancer Clinical Trial page.

Latest updates to the INEC: Irradiation and Nivolumab in Esophageal Cancer Clinical Trial page
- Check4 days agoChange DetectedAdded Revision: v3.5.2; Deleted Revision: v3.5.0.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check33 days agoChange DetectedAdded Revision: v3.5.0; Removed Revision: v3.4.3.SummaryDifference0.1%

- Check40 days agoChange Detected- Revision updated from v3.4.2 to v3.4.3; no study content or essential page data appears to be affected.SummaryDifference0.1%

- Check68 days agoChange DetectedAdded Revision: v3.4.2 and removed the government funding lapse notice as well as the previous Revision: v3.4.1.SummaryDifference0.4%

- Check75 days agoChange DetectedAdded a government funding lapse notice about the NIH Clinical Center status and updated the page revision to v3.4.1, while removing the previous v3.4.0 reference.SummaryDifference0.4%

- Check83 days agoChange DetectedAdded a glossary toggle (Show glossary) and made minor wording changes to metadata, including capitalization tweaks and a new Revision: v3.4.0. These updates replace the previous wording (met QC Criteria, No FEAR Act data, Revision: v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to INEC: Irradiation and Nivolumab in Esophageal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the INEC: Irradiation and Nivolumab in Esophageal Cancer Clinical Trial page.